Arsanis Reports Financial Results for Third Quarter 2018
November 09, 2018 08:00 ET
|
Arsanis, Inc.
WALTHAM, Mass. and VIENNA, Austria, Nov. 09, 2018 (GLOBE NEWSWIRE) -- Arsanis, Inc. (NASDAQ: ASNS), a clinical-stage biopharmaceutical company focused on applying monoclonal antibody (mAb)...